Lipid peroxidation and protective enzymes during myocardial infarction
- 15 February 1991
- journal article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 196 (2-3) , 119-125
- https://doi.org/10.1016/0009-8981(91)90064-j
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosisPublished by Elsevier ,2003
- Decreased defence against free radicals in rat heart during normal reperfusion after hypoxic, ischemic and calcium-free perfusionLife Sciences, 1984
- Plasma malonaldehyde levels during myocardial infarctionClinica Chimica Acta; International Journal of Clinical Chemistry, 1983
- Lipid Peroxidation and Acute Myocardial IschemiaPublished by Springer Nature ,1983
- Oxygen toxicityThe American Journal of Medicine, 1980
- Prostacyclin-dependent differences in TXA2 formation by platelets from normal and atherosclerotic rabbitsAtherosclerosis, 1979
- Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbitsAtherosclerosis, 1978
- [41] Preparation and assay of superioxide dismutasesPublished by Elsevier ,1978
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregationProstaglandins, 1976